UnknownPhase 1

Safety Study of an Oral Pro-boneTM, Administered to Post Menopausal Osteopenic Women

20 participantsStarted 2011-09

Plain-language summary

Recent studies have shown that inhibition of Aquaporine-9 channels may ameliorate the bone degradation process. Pro-bone is an AQ - 9 channels inhibitor. This study is design to evaluate the safety of Pro-bone.

Who can participate

Age range

45 Years – 65 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. 8 weeks or longer for any prior use of estrogen and/or progestin products.
. 6 months or longer for prior progestin injectable drug therapy.
. Women between 45 and 65 years (inclusive) of age.
. BMI 22-30 (inclusive)
. Non-smoking (by declaration) for a period of at least 6 months.
. Subjects able to adhere to the visit schedule and protocol requirements and be available to complete the study.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Adverse events recorded throughout the study

Timeframe: 4 weeks

Blood and urinalysis values assessed at pre-dose and according to study design.

Timeframe: 4 weeks

Trial details

NCT IDNCT01397838

SponsorOsteoBuild Ltd.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2011-12

View on ClinicalTrials.gov More Osteopenia trials